echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JAMA Sub-Issue: 29 Years follow-up report revealed! Recognized as "women have a lower risk of cardiovascular disease", why did type 1 diabetes roll over?

    JAMA Sub-Issue: 29 Years follow-up report revealed! Recognized as "women have a lower risk of cardiovascular disease", why did type 1 diabetes roll over?

    • Last Update: 2022-09-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the general population, women have a lower


    This study compared cardiometabolic risk factor profiles, cardiac protection drug use, and CVD events in men and women with type 1 diabetes and followed up for approximately 29 years in the Diabetes Control and Complications Trial/Diabetes Intervention and Complication Epidemiology (DCCT/EDIC) study


    Results Showed that a total of 1441 patients with type 1 diabetes mellitus (mean [SD] age at DCCT baseline, 26.


    Women reached the recommended blood pressure (i.


    During dcct/EDIC, 113 women (16.


    Guidelines for treatment to waist circumference, blood pressure, lipids, and HbA1c reduced the risk of any CVD by 30% to 57%, while meeting lipid targets was associated


    These findings suggest that although cardiometabolic risk factor profiles are more favorable, the burden of CVD events in women with type 1 diabetes is not significantly lower than in men, suggesting that the clinical impact of cardiometabolic risk factors is greater


    Original source:

    Braffett BH, Bebu I, El ghormli L, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.